Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 338, Issue 5, pp 536–542 | Cite as

Probable involvement of vascular angiotensin II formation in the β2-adrenoceptor-mediated facilitation of the neurogenic vasopressor response in the pithed rat

  • E. Schfcker
  • K. Erkens
  • M. Göthert
Article
  • 11 Downloads

Summary

Rats were pithed, vagotomized and adrenalectomized and the effect of procaterol on the pressor response to electrical stimulation of the thoracolumbar preganglionic sympathetic outflow from the spinal cord or to exogenous noradrenaline was studied in the absence and presence of β-adrenoceptor antagonists and drugs interfering with the renin-angiotensin system.
  1. 1.

    Basal diastolic blood pressure was decreased by captopril, ramiprilate (angiotensin converting enzyme inhibitors), saralasin (an angiotensin II receptor antagonist), pepstatin A (a protease inhibitor with renin antagonistic properties) and by functional nephrectomy (ligation of both renal hili), but was not affected by procaterol (a β2-adrenoceptor agonist), nebivolol (a β1-adrenoceptor antagonist) and ICI 118,551 (erythro-dl-1-(7-methylindan-4yloxy)-3-isopropylaminobutan-2-ol; a β2-adrenoceptor antagonist).

     
  2. 2.

    The vasopressor response induced by electrical stimulation of the preganglionic sympathetic nerve fibres was increased by procaterol, whereas the increase in blood pressure evoked by exogenous noradrenaline was not affected. The pressor response to both electrical stimulation and exogenous noradrenaline was decreased by captopril, ramiprilate, saralasin and nephrectomy but was not affected by nebivolol and TO 1I8,551.

     
  3. 3.

    The facilitatory effect of procaterol on the neurogenic, electrically induced pressor response, which was also obtained when basal blood pressure was decreased by nephrectomy and increased by Lys8-vasopressin, was abolished by ICI 118,551 but not affected by nebivolol. Under none of these experimental conditions did procaterol alter the vasopressor response to exogenous noradrenaline. electrically induced rise in blood pressure was abolished by captopril, ramiprilate, saralasin and pepstatin A. The facilitatory effect of procaterol on neurogenic pressor effect was also abolished by captopril and saralasin in nephrectomized rats and by captopril in rats in which basal blood pressure was restored to control values by Lys8-vasopressin. The pressor response to exogenous noradrenaline was not altered by procaterol under any of these experimental conditions.

     
  4. 4.

    The present results suggest that the β2-adrenoceptor-mediated facilitation of noradrenaline release in the resistance vessels may involve local formation (i. e. synthesis in the blood vessel wall) of angiotensin II which in turn seems to activate presynaptic facilitatory angiotensin II receptors on the sympathetic nerve fibres.

     

Key words

Pithed rat β2-Adrenoceptors Vascular renin-angiotensin system Presynaptic angiotensin II receptors Sympathetic nerves 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aiken JW, Vane JR (1970) The renin-angiotensin system: inhibition of converting enzyme in isolated tissues. Nature 228:30–34CrossRefGoogle Scholar
  2. Borkowski KR, Quinn P (1984a) Facilitation by β-adrenoceptors of stimulation-induced vasoconstriction in pithed spontaneously hypertensive rats. J Autonom Pharmacol 4:127–131CrossRefGoogle Scholar
  3. Borkowski KR, Quinn P (1984b) β2-Adrenoceptors mediate adrenaline's facilitation of neurogenic vasoconstriction. Eur J Pharmacol 103:339–342CrossRefGoogle Scholar
  4. Deboben A, Inagami T, Ganten D (1983) Tissue renin. In: Genest J, Kuchel O, Hamet P, Cantin M (eds) Hypertension: Physiopathology and treatment. McGraw Hill, New York, pp 194209Google Scholar
  5. De Jonge A, Knape JThA, van Meel JCA, Kalkman HO, Wilffert B, Thoolen MJMC, Timmermans PBMWM, van Zwieten PA (1982) Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by α1- and α2-adrenoceptor stimulation in pithed normotensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 321:309–313CrossRefGoogle Scholar
  6. De Jonge A, Knape JThA, van Meel JCA, Kalkman HO, Wilffert B, Thoolen MJMC, van Brummelen P, Timmermans PBMWM, van Zwieten PA (1983) Effect of captopril on sympathetic neurotransmission in pithed normotensive rats. Eur J Pharmacol 88:231–240CrossRefGoogle Scholar
  7. Dengler W (1956) Über einen reninartigen Wirkstoff in Arterienextrakten. Arch Exp Path Pharmakol 227:481–487Google Scholar
  8. Desjardins-Giasson S, Gutkowska J, Garcia P, Genest J (1981) Renin substrate in rat mesenteric artery. Can J Physiol Pharmacol 59:528–532CrossRefGoogle Scholar
  9. Dzau VJ (1984) Vascular renin-angiotensin: A possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol 6:377–382CrossRefGoogle Scholar
  10. Göthert M (1988) Transsynaptic modulation of noradrenaline release in blood vessels by locally generated angiotensin peptides. In: Bevan JA, Majewski H, Maxwell RA, Story DF (eds) Vascular neuroeffector mechanisms. Receptors, ion-channels, second messengers and endogenous mediators. IRL Press, Oxford Washington, pp 169–174Google Scholar
  11. Göthert M, Kollecker P (1986) Subendothelial β2-adrenoceptors in the rat vena cava: Facilitation of noradenaline release via local stimulation of angiotensin 11 synthesis. Naunyn-Schmiedeberg's Arch Pharmacol 334:156–165CrossRefGoogle Scholar
  12. Gould AB, Skeggs LT, Kahn JR (1964) The presence of renin activity in blood vessel walls. J Exptl Med 119:389–399CrossRefGoogle Scholar
  13. Kaufman LJ, Vollmer RR (1985) Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats. J Pharmacol Exp Ther 235:128–134PubMedGoogle Scholar
  14. Kawasaki H, Cline WH, Su C (1984) Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats. J Pharmacol Exp Ther 231:23–32PubMedGoogle Scholar
  15. Lazar J, Oster P, Gross F, Hackenthal E (1974) Demonstration of the in vivo action of pepstatin: effects on plasma angiotensin II concentration. Biochem Pharmacol 23:2776–2778CrossRefGoogle Scholar
  16. Majewski H (1983) Modulation of noradrenaline release through activation of presynaptic β-adrenoceptors. J Autonom Pharmacol 3:47–60CrossRefGoogle Scholar
  17. Malik KU, Nasjletti A (1976) Facilitation of adrenergic transmission by locally generated angiotensin 1I in rat mesenteric arteries. Circulation 38:26–30CrossRefGoogle Scholar
  18. Misu Y, Kubo T (1986) Presynaptic β-adrenoceptors. Med Res Rev 6:197–225CrossRefGoogle Scholar
  19. Nakamaru M, Jackson EK, Inagami T (1986a) β-Adrenoceptor-mediated release of angiotensin 11 from mesenteric arteries. Am J Physiol 250:H144-H148PubMedGoogle Scholar
  20. Nakamaru M, Jackson EK, Inagami T (1986b) Role of vascular angiotensin II released by β-adrenergic stimulation in rats. J Cardiovasc Pharmacol 8 (Suppl. 10):S1-S5CrossRefGoogle Scholar
  21. Schlicker E, Erkens K (1988) Involvement of local angiotensin (ANG) II formation in the β2-adrenoceptor-mediated increase in neurogenic vasopressor response in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 337 (Suppl.):R78CrossRefGoogle Scholar
  22. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124CrossRefGoogle Scholar
  23. Van de Water A, Janssens W, Van Nueten J, Xhonneux R, De Cree J, Verhaegen H, Reneman RS, Janssen PAJ (1988) Pharmacological and haemodynamic profile of nebivolol, a chemically novel, potent, and selective β1-adrenergic antagonist. J Cardiovasc Pharmacol 11:552–563CrossRefGoogle Scholar
  24. Velletri P, Bean BL (1982) The effects of captopril on rat aortic angiotensin-converting enyzme. J Cardiovasc Pharmacol 4:315–325CrossRefGoogle Scholar
  25. Westfall TC (1977) Local regulation of adrenergic neurotransmission. Physiol Rev 57:659–728CrossRefGoogle Scholar
  26. Ziogas J, Story DF (1987) Tissue and species variability in the involvement of angiotensin II in the isoprenaline-induced enhancement of transmitter noradrenaline release. Xth International Congress of Pharmacology 1987; Abstract:P1395Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • E. Schfcker
    • 1
  • K. Erkens
    • 1
  • M. Göthert
    • 1
  1. 1.Institut für Pharmakologie und Toxikologie der Rheinischen Friedrich-Wilhelms-UniversitätBonnGermany

Personalised recommendations